MARC-PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of MARC-PHARMA is 2.9% (moderate). The 2025 annual accounts show equity of €21,193 and a net result of €16,193. Its solvency ranks better than 72% of 22,479 sector peers (NACE 47, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
History
On 26 December 2024, MARC-PHARMA was incorporated as a private limited company, with a starting capital of €5,000.12 FAIDHERBE Marc-Louis Hubert has served as administrateur non statutaire et de représentant permanent of the company since 2024.2 The company has filed annual accounts once, for financial year 2025.3
Acts, filings and financial milestones
30-12
Gazette deed
IncorporationAppointment: FAIDHERBE Marc-Louis Hubert (administrateur non statutaire et de représentant permanent) · Founding capital · Registered office clause6 facts ▸
- Incorporation, 26-12-2024
- Founding capital, €5,000
- Registered office clause, “5651 Walcourt (Tarcienne),Route de Philippeville 57” (deed in French)
- Board rule, 1
- Director appointment, FAIDHERBE Marc-Louis Hubert (administrateur non statutaire et de représentant permanent)
- Pre-incorporation commitments, “takeover, engagements obligations et activités au nom et pour compte société en formation” (deed in French)